Opportunity Information: Apply for PAR 20 081
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21 - Clinical Trial Not Allowed), Funding Opportunity Number PAR-20-081, is a National Institutes of Health (NIH) discretionary grant program designed to fund innovative, early-stage research that digs into why chronic liver diseases and liver cancer do not affect all populations in the United States equally. The core aim is to support multidisciplinary exploratory and developmental projects that move beyond describing disparities and instead identify the underlying causes and biological, environmental, behavioral, and social mechanisms that drive these unequal outcomes. The opportunity is intended for projects that are high-impact and hypothesis-generating, with an emphasis on novel ideas and approaches that can later be scaled into larger, more definitive studies.
This announcement uses the NIH R21 mechanism, which typically supports shorter-term, exploratory research rather than large, long-running programs. Under this opportunity, clinical trials are not allowed, meaning applicants should not propose studies that prospectively assign human participants to interventions to evaluate health outcomes. Research can still involve human populations and human data, but it must stay within the boundaries of non-trial study designs (for example, observational studies, analyses of existing cohorts or biorepositories, mechanistic studies using human specimens, or secondary data analyses), as long as the proposed work does not meet NIH definitions of a clinical trial.
The funding information provided lists an award ceiling of $200,000, indicating the maximum amount available per award under the terms summarized here. The opportunity is categorized under Education and Health funding activities and is associated with multiple CFDA numbers (93.307, 93.393, 93.394, 93.395, 93.396, 93.399), reflecting NIH program alignment across relevant institutes and disease areas connected to liver disease, cancer, and health disparities research.
Eligibility is broad and includes a wide range of U.S.-based organizations and governmental entities. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities and Indian housing authorities; Native American tribal organizations that are not federally recognized tribal governments; nonprofits both with and without 501(c)(3) status (as long as they are not institutions of higher education); for-profit organizations other than small businesses; and small businesses. The announcement also explicitly highlights additional eligible applicant types, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal government agencies, and U.S. territories or possessions. This broad eligibility reflects the program’s emphasis on reaching institutions and communities that are often central to disparities-focused research and community-engaged scientific work.
At the same time, there are clear restrictions related to foreign participation. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components are allowed when they meet the NIH definition in the NIH Grants Policy Statement, which generally means a U.S. applicant organization may include specific foreign elements in the project when scientifically justified and permitted under NIH policy, even though the applicant organization itself must be domestic.
The opportunity was created on January 14, 2020, and the original closing date listed is April 1, 2022. While that closing date suggests the specific cycle summarized here may have ended, the program title and PAR format indicate it may have had multiple receipt dates or related reissued announcements over time, so applicants typically need to confirm the current status and active due dates in NIH systems before preparing an application.
Overall, PAR-20-081 is geared toward generating new mechanistic insights into liver disease and liver cancer disparities in the U.S. by supporting cross-disciplinary, exploratory research that can identify causal pathways and actionable targets for future interventions, without conducting clinical trials within the R21 project itself.Apply for PAR 20 081
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21- Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.307, 93.393, 93.394, 93.395, 93.396, 93.399.
- This funding opportunity was created on 2020-01-14.
- Applicants must submit their applications by 2022-04-01. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: Community Food Projects Program
Previous opportunity: Support for Small Business Innovation Research (SBIR) to Develop New Technologies for Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R43/R44 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 20 081
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 20 081) also looked into and applied for these:
| Funding Opportunity |
|---|
| Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional) Apply for RFA CA 20 005 Funding Number: RFA CA 20 005 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional) Apply for RFA CA 20 004 Funding Number: RFA CA 20 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) Apply for RFA NS 20 028 Funding Number: RFA NS 20 028 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| HIV/AIDS and the Tumor Niche (U54 Clinical Trial Not Allowed) Apply for RFA CA 20 016 Funding Number: RFA CA 20 016 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,000,000 |
| Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) Apply for RFA CA 20 008 Funding Number: RFA CA 20 008 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional) Apply for PAR 20 092 Funding Number: PAR 20 092 Agency: National Institutes of Health Category: Education, Health Funding Amount: $3,000,000 |
| HEAL Initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development (R61/R33 - Clinical Trial Not Allowed) Apply for RFA HL 20 031 Funding Number: RFA HL 20 031 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) Apply for PAR 20 077 Funding Number: PAR 20 077 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Training Modules to Enhance the Rigor, Reproducibility and Responsible Conduct of Biomedical Data Science Research (R25 - Clinical Trial Not Allowed) Apply for RFA GM 20 001 Funding Number: RFA GM 20 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Implementing the HIV Service Cascade for Justice-Involved Populations (U01 Clinical Trial Required) Apply for RFA DA 20 028 Funding Number: RFA DA 20 028 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploring the Roles of Biomolecular Condensates (BMCs) in HIV replication, latency, or pathogenesis in the context of substance use disorders (R21/R33 Clinical Trial Not Allowed) Apply for RFA DA 21 004 Funding Number: RFA DA 21 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) Apply for PAR 20 116 Funding Number: PAR 20 116 Agency: National Institutes of Health Category: Education, Health Funding Amount: $475,000 |
| National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U01 Clinical Trial Optional) Apply for PAR 20 118 Funding Number: PAR 20 118 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U19 Clinical Trial Optional) Apply for PAR 20 119 Funding Number: PAR 20 119 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Strengthening the Impact of Community Health Workers on the HIV Care Continuum in the US (R01 Clinical Trial Optional) Apply for RFA NR 20 002 Funding Number: RFA NR 20 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) Apply for RFA CA 20 033 Funding Number: RFA CA 20 033 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed) Apply for PAR 20 136 Funding Number: PAR 20 136 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) Apply for PAR 20 131 Funding Number: PAR 20 131 Agency: National Institutes of Health Category: Education, Health Funding Amount: $450,000 |
| Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional) Apply for RFA CA 20 027 Funding Number: RFA CA 20 027 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional) Apply for RFA CA 20 028 Funding Number: RFA CA 20 028 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 20 081", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
